IOVANCE BIOTHERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Iovance Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$102M, a 7.42% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$459M, a 7.21% decline year-over-year.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$461M, a 15.5% decline from 2022.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$399M, a 16.4% decline from 2021.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$343M, a 30.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$461M -$61.7M -15.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$399M -$56.2M -16.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$343M -$80.8M -30.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$262M -$55.1M -26.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$207M -$78.6M -61.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$128M -$35.4M -38.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$92.9M -$39.2M -73.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$53.6M -$25.8M -92.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$27.9M -$15.8M -131% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$12M +$10.6M +46.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 -$22.6M -$14.5M -178% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 -$8.13M +$13.1M +61.7% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 -$21.2M -$20.4M -2502% Jan 1, 2011 Dec 31, 2011 10-K 2013-09-23
2010 -$815K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.